Skip to product information
1 of 1

PE-Cy7 Rat Anti-Mouse CD223 Antibody (C9B7W)

PE-Cy7 Rat Anti-Mouse CD223 Antibody (C9B7W)

Catalog Number: S0B80658 Application: FCM Reactivity: Ms Conjugation: PE-Cy7 Brand: Starter
Price:
Regular price $85 USD
Regular price Sale price $85 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rat
Antigen CD223
Synonyms Lymphocyte activation gene 3 protein; LAG-3; Activation-induced cytidine deaminase-linked autoimmunity protein (Aida); Lag3
Location Cell membrane
Accession Q61790
Clone Number C9B7W
Antibody Type Rat mAb
Isotype IgG1,k
Application FCM
Reactivity Ms
Positive Sample mouse CD3, CD28 and IL-2 antibody treated C57BL/6 mouse splenocytes
Purification Protein G
Concentration 0.2 mg/ml
Conjugation PE-Cy7
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.09% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 0.25μg per million cells in 100μl volume Ms

Background

CD223, also known as LAG-3 (lymphocyte activation gene-3), is a type I transmembrane protein belonging to the immunoglobulin (Ig) superfamily. It is expressed on the surface of activated T cells, regulatory T cells (Tregs), natural killer (NK) cells, and some other immune cells. Structurally, it is similar to CD4 and has a higher binding affinity to MHC class II molecules than CD4. LAG-3 primarily functions as an immune checkpoint receptor, negatively regulating T-cell activation, proliferation, and cytokine production. In cancer and chronic infections, elevated LAG-3 expression is associated with T cell exhaustion, limiting anti-tumor and antiviral responses. Due to its significant role in immune regulation, LAG-3 has become a promising target for cancer immunotherapy and the treatment of autoimmune disorders.

Picture

FC

Flow cytometric analysis of Mouse CD223 expression on mouse CD3, CD28 and IL-2 Antibody treated C57BL/6 mouse splenocytes. C57BL/6 mouse splenocytes untreated (left panel) or treated 96h with anti-mouse CD3, CD28, IL-2 (right panel) then stained with Brilliant Violet 421™ Rat Anti-Mouse CD4 and SDT PE-Cy7 Rat Anti-Mouse CD223 Antibody at 1.25 μl/test treated with True-Stain Monocyte Blocker™. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.